• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Key Chart Favors a Nice Rise in Abbott Labs Later This Year

The technical signals indicate the odds of further weakness in the health care company's shares are low.
By BRUCE KAMICH
May 12, 2021 | 08:06 AM EDT
Stocks quotes in this article: ABT

COVID is still very much a part of our lives, Jim Cramer told his "Mad Money" viewers Tuesday night. That means it's important to make sense of where we are in the pandemic, what threats still remain and what the future might hold.

Cramer went right to someone on the front lines of the pandemic as he spoke to Robert Ford, president and CEO of Abbott Laboratories (ABT) , to learn about the latest on testing in America.

Abbott was one of the first to provide testing before vaccines became available and it is now one of the leaders post-vaccine, with rapid COVID testing options. Ford said Abbott's goal is to make rapid testing affordable and accessible to everyone who needs it.

Abbott's rapid test kits are currently available in 20,000 pharmacies across the county and will soon expand to more than 30,000 locations as manufacturing and distribution continues to expand.

Let's check out the charts of Abbott, which is a holding of Cramer's Action Alerts PLUS charitable trust. In our review of Abbott on March 26 we wrote, "ABT reached our $125 target in February and maybe some of you took some money off the table. The charts are more mixed now, so traders should raise stops to $114 on the balance of their position."

In this daily bar chart of ABT, below, we can see that prices have not tested the March low and thus have not elected our suggested $114 sell stop. ABT is trading below the declining 50-day moving average line but above the rising 200-day moving average. The On-Balance-Volume (OBV) line has declined a little from its new high for the move up last month. The recent increase in aggressive selling may be temporary. The Moving Average Convergence Divergence (MACD) oscillator fell below the zero line recently for a new outright sell signal.

In this weekly bar chart of ABT, below, we can see that prices are in a longer-term uptrend above the rising 40-week moving average line. The weekly OBV line has been stalled for at least three months, telling us that there is more of a balance between buyers and sellers of ABT. The MACD oscillator is pointed down but is still in positive territory above the zero line.

In this daily Point and Figure chart of ABT, below, we can see that the software is projecting the $109 area as a potential downside price target. If ABT did decline toward $109 the chart shows plenty of potential support, so the odds of further weakness are low.

In this weekly close-only Point and Figure chart of ABT, below, we used a traditional even-dollar scaling. Here the software is projecting the $202 area as a tentative longer-term price objective.

Bottom line strategy: The broad market is undergoing a lot of shifts and turns, also called rotation. Shares of ABT might slip a little during this adjustment period, but the weekly Point and Figure chart suggests we could see significant gains later in 2021. Continue to hold remaining longs. Continue with a stop at $114. Add to longs on strength above $126.

(ABT is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells these stocks? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Healthcare | Life Sciences | Pharmaceuticals | Mad Money | Executive Interview | Real Money | Coronavirus

More from Stocks

Inflation May Be Slowing, but That Doesn't Mean the Fed Is

Maleeha Bengali
Aug 12, 2022 1:00 PM EDT

Investors are cheering the slowing pace of inflation's increase, but prices are still way up, which means the Fed is going to continue to take liquidity out of the system.

3 International Energy Stocks for Dividends And Growth

Bob Ciura
Aug 12, 2022 11:30 AM EDT

International companies often trade at discounts to their American counterparts, which can mean better value and better yields as well.

It's Far Too Early for a Victory Lap in the Race Against Inflation

Bret Jensen
Aug 12, 2022 10:45 AM EDT

Prices are continuing to rise, particularly for labor and rent, and that could put a drag on profits and consumer spending.

Fossil Group Sounds the Alarm While NL Industries Rewards Its Shareholders

Jonathan Heller
Aug 12, 2022 10:30 AM EDT

The former signaled lower revenues for the year while the latter declared a healthy special dividend.

The TJX Companies Reports Next Week, But There's a Trade Here

Stephen Guilfoyle
Aug 12, 2022 10:15 AM EDT

Many large chain retailers report during the week to round out earnings season, along with the July Retail Sales.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:44 AM EDT PETER TCHIR

    CPI Beats Expectations, But Maybe Not the 'Whisper'?

    Slightly better-than-expected inflation across the...
  • 01:44 PM EDT STEPHEN GUILFOYLE

    This Holding Lights Up With Strong Earnings

    Check out the latest from TheStreet's Stocks Under...
  • 09:24 AM EDT PETER TCHIR

    Jobs Report Reaction: Incredibly Strong, But Questions to Ask

    An incredibly strong July jobs report. Not only d...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login